Virtual Reality for Chronic Pain and Opioid Use Disorder Pilot
CompletedNot applicableNCT05546749
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a pilot feasibility study of a virtual reality device for patients with co-morbid chronic pain and opioid use disorder.
Study details
- Official title
- Virtual Reality Treatment in a Methadone Maintenance Treatment Program for Chronic Pain and Opioid Use Disorder
- Conditions
- Interventions
- Device: RelieVRx
- Device: Sham VR
- Sponsor
- Albert Einstein College of Medicine
- Collaborators
- National Institute on Drug Abuse (NIDA)
- Start date
- 2023-02-08
- Primary completion
- 2023-07-12
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. ≥18 years old 2. English proficiency 3. receiving methadone treatment for DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition) confirmed Opioid Use Disorder (OUD) in the Montefiore network for at least 12 weeks, with no dose change in 14 days to ensure treatment stability 4. chronic pain of at least moderate pain severity (score ≥4 on the Pain, Enjoyment of Life, and General Activity (PEG) scale) 5. willingness to participate in all study components 6. ability to provide informed consent, assessed using consent teach-back Exclusion Criteria: 1. conditions that could make participation in VR hazardous or cause adverse effects (current or prior diagnosis of epilepsy, seizure disorder, dementia, or migraines, any medical condition predisposing to nausea or dizziness, hypersensitivity to flashing light or motion) 2. conditions that could prevent proper use of the VR headset (stereoscopic vision or severe hearing impairment, or injury to eyes, face, or neck that prevents use of the VR headset) 3. acute exacerbation of psychiatric conditions that preclude the ability to participate in the study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05546749